Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 20

NCT ID: NCT01679847 Not yet recruiting - Cancer Clinical Trials

Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.

Start date: September 2012
Phase: Phase 1
Study type: Observational

The purpose of this study is to elucidate the pharmacokinetics and the blood-brain barrier penetration of the elemene.

NCT ID: NCT01589406 Not yet recruiting - Cancer Clinical Trials

Quality of Life and Sexuality in Women With Gynaecological Cancer

Start date: June 2012
Phase: N/A
Study type: Observational

Patients with premalignant (CIN3) and malignant cervical cancer will asked to complete questionnaires regarding intimacy (ENRICH) and life adaptation (PAIS) before treatment (surgery or radiotherapy) and after completion of treatment in order to estimate the influence of disease and treatment on quality of life indices.

NCT ID: NCT01584115 Not yet recruiting - Lung Cancer. Clinical Trials

Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)

Start date: July 2012
Phase: Phase 1/Phase 2
Study type: Interventional

This study is a clinical trial phase I/II. Its goal is to determine the safety, tolerability, immunogenicity and efficacy of a therapeutic vaccine with the tumor antigen NY-ESO-1 combined with the adjuvant MPLA from B. pertussis in cancer patients.

NCT ID: NCT01562067 Not yet recruiting - Cancer Clinical Trials

Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy

Start date: March 2012
Phase: N/A
Study type: Observational

Cervical tumors are characterized by vascular changes (in terms of quantity, volume and Flows) in the tumor. Due to a good access to the cervix through the vagina, these parameters can be assessed using a three dimensional supersonic. Sonographic characteristics of tumor indices measures before and after oncological treatments may shed light on the patient's prognosis.

NCT ID: NCT01481532 Not yet recruiting - Cancer Clinical Trials

Open Label Clinical Trial of Intravenous Crotoxin Part 3

Start date: August 2024
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to assess whether human subjects can be made tolerant to intravenously administered Crotoxin and achieve higher and more therapeutically effective doses levels without the previously reported adverse effects associated with bolus i.m. administration.

NCT ID: NCT01395680 Not yet recruiting - Cancer Clinical Trials

Trajectories of Regenerating Family Resilience in Adolescents With Cancer

Start date: August 2011
Phase: N/A
Study type: Observational

Family resilience is an important strength to help family to manage life challenge successfully, and to reorganize family function. However, few studies have showed the trajectory of family resilience in adolescents with cancer over time. The purposes of this study are to know the trend of family resilience in adolescents with cancer from previous 3 months to the first year of newly diagnosed, and to examine the relationships among family members' stress, family satisfaction, and family resilience in adolescents with cancer.

NCT ID: NCT01291628 Not yet recruiting - Cancer Clinical Trials

Prevention of Capecitabine Induced Hand and Foot Syndrome

Start date: January 2012
Phase: N/A
Study type: Interventional

Capecitabine is a common anti cancer drug. One of the most common side effects is a syndrome called hand and foot syndrome which comprises of hands and feet redness, swelling, dryness and painful sores. Quite often the drug dose is reduced to suboptimal level due to this side effect. There is no way to prevent or an effective way to treat this side effect. The investigators aim is to investigate whether wearing socks which contain copper fibers may prevent or alleviate the patient symptoms.

NCT ID: NCT01227109 Not yet recruiting - Cancer Clinical Trials

Procalcitonin as a Marker of Infection in Cancer Patients

Start date: February 2011
Phase: N/A
Study type: Observational

Infections pose a serious threat to cancer patients in chemotherapy. Prompt diagnosis and treatment is of paramount importance as infections may be life-threatening in immune-compromised individuals. Traditionally, the C-reactive protein (CRP) has been used as a marker of infection. However, the CRP is also often elevated in cancer patients and as a marker CRP may be unreliable in cancer patients. Other markers for infection includes procalcitonin which has been showed to be of some value for the diagnose of bacterial infections. This study examines procalcitonin as a potential marker of bacterial infection in cancer patients.

NCT ID: NCT01103700 Not yet recruiting - Cancer Clinical Trials

Evaluation of Multidisciplinary Palliative Care on Terminal Cancer Patients in Taiwan

Start date: May 2010
Phase: N/A
Study type: Observational

The purpose of the study is to compare the quality of dying and death of terminal cancer patients from the perspectives of medical staff and main care giver (family). The hypothesis is that their view points will be different.